COMPARATIVE ANALYSIS OF THE EFFICACY OF CONTINUOUS VENO-VENOUS HEMODIALYSIS AND PERITONEAL DIALYSIS IN CHILDREN WITH TYPICAL HEMOLYTIC-UREMIC SYNDROME
Description
This dataset accompanies a single-center retrospective comparative cohort study of renal replacement therapy in children with typical hemolytic uremic syndrome (tHUS) and dialysis-dependent acute kidney injury (AKI), conducted at St. Vladimir Children's City Clinical Hospital in Moscow, Russia, between 2020 and 2023. The study investigated whether continuous venovenous hemodialysis (CVVHD) and peritoneal dialysis (PD) differ in their ability to correct biochemical disturbances associated with AKI and whether these differences are associated with short-term clinical outcomes. The dataset includes individual-level clinical and laboratory observations from 60 children: 29 treated with CVVHD and 31 treated with PD. Two patients with renal cortical necrosis were excluded from the comparative cohort. Direct patient identifiers and selected clinical variables were removed from the shared dataset. The accompanying files contain the study's comparative tables and figures as presented in the associated manuscript. These materials describe baseline clinical characteristics, laboratory parameters, longitudinal changes in serum creatinine, urea, lactate dehydrogenase, and base excess, treatment characteristics, and clinical outcomes. The findings indicate that CVVHD was associated with faster correction of azotemia and metabolic acidosis and a shorter duration of renal replacement therapy. However, no statistically significant differences were identified in the duration of anuria, recovery of urine output, or length of hospitalization. Proteinuria at hospital discharge was more frequent in the CVVHD group. The dataset is intended to support independent examination of the reported findings, secondary statistical analyses, and future comparative research. Interpretation should account for the retrospective nonrandomized design, baseline differences between treatment groups, missing observations, and the exclusion of selected variables for confidentiality reasons. The observed associations should not be interpreted as evidence of causality or definitive superiority of either treatment modality.